Sanofi Genzyme, the specialty care global business unit of Sanofi, focuses on rare diseases, rare
blood disorders, multiple sclerosis, oncology, and immunology. We help people with debilitating and
complex conditions that are often difficult to diagnose and treat. Our approach is shaped by our
experience developing highly specialized treatments and forging close relationships with physician
and patient communities. We are dedicated to discovering and advancing new therapies, providing
hope to patients and their families around the world. Learn more at www.sanofigenzyme.com.